Immediate Impact

7 by Nobel laureates 27 from Science/Nature 64 standout
Sub-graph 1 of 22

Citing Papers

Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease
2025 StandoutNature
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
3 intermediate papers

Works of Willem Weimar being referenced

Randomized Phase 2b Trial of Tofacitinib (CP-690,550) in De Novo Kidney Transplant Patients: Efficacy, Renal Function and Safety at 1 Year
2012
Phase 1 Dose-Escalation Study of CP-690 550 in Stable Renal Allograft Recipients: Preliminary Findings of Safety, Tolerability, Effects on Lymphocyte Subsets and Pharmacokinetics
2008
and 6 more

Author Peers

Author Last Decade Papers Cites
Willem Weimar 5467 3779 3748 417 11.2k
Jesse D. Schold 5165 3547 4379 356 11.9k
Jeremy R. Chapman 8600 3205 5725 318 14.8k
Ajay K. Israni 7331 3824 7740 293 14.1k
Edgar L. Milford 5387 3081 4144 164 13.0k
Hans W. Sollinger 6420 2753 7608 344 12.3k
Daniel C. Brennan 7285 3067 4868 347 15.2k
Johan W. de Fijter 5113 1290 3287 320 10.9k
Jon J. Snyder 7960 4185 8496 256 16.2k
Krista L. Lentine 5003 4388 4457 368 11.2k
Rainer Oberbauer 3893 1395 3089 295 10.0k

All Works

Loading papers...

Rankless by CCL
2026